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Aim: We aimed to characterize the myofibrillar components of diastolic heart failure 
(heart failure with preserved ejection fraction (HFPEF)). 
Methods: Biophysical and biochemical characteristics of permeabilized cardiomyocytes 
isolated from left ventricular biopsies of patients with or without HFPEF, and/or with 
aortic stenosis (AS), or diabetes mellitus (DM) were determined under in vitro 
conditions. 
Results: Passive force (Fpassive) of cardiomyocytes isolated from HFPEF patients was 
significantly higher than in controls. Moreover, Fpassive correlated with left ventricular 
end-diastolic pressure (LVEDP) and left ventricular (LV) end-diastolic wall stress. High 
Fpassive of cardiomyocytes from HFPEF patients was reversible as it was normalized 
following the in vitro administration of protein kinase A (PKA) or protein kinase G 
(PKG) or antioxidants (e.g. dithiothreitol). The three-fold rise in Fpassive of HF 
cardiomyocytes compared to AS cardiomyocytes was partially attributed to a shift in titin 
isoform phosphorylation with relative hypophosphorylation of the stiff N2B titin isoform 
when compared to that of the more compliant N2BA isoform. Fpassive was augmented in 
patients with AS and DM. An additional component of increased cardiomyocyte passive 
stiffness was associated with myofilament protein oxidation. 
Conclusions: Changes in the levels of expression, phosphorylation and oxidation of 
myofibrillar proteins of LV cardiomyocytes may contribute to the development of 
HFPEF. 
Keywords: heart failure, diastolic dysfunction, cardiomyocyte, passive force, human 
myocardial biopsy 
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Aim: The aim of this presentation is to discuss gene-environment interaction in the 
development of cardiovascular disease. This will be demonstrated on the example of the 
gene for connexin 37. Previously, we observed that the association between this gene and 
risk for ischemic heart disease (IHD) is modified by female gender and smoking. 
Recently, we further expanded the data by measuring this gene polymorphism in patients 
with IHD from Hungary and Croatia.  
Methods: Study population comprised 704 women and 1, 884 men with IHD.  As a 
control group we used population of 1,368 women and 1,191 women from the population 
based (post-MONICA) study. We compared the prevalence of connexin 37 gene variants 
between patients and controls after stratifying them by gender and smoking status. 
Differences were evaluated by chi-square test (STATA program). 
Results: The frequency of genotypes in the whole group significantly differed between 
women smokers and non-smokers with IHD. There was significantly lower frequency of 
T allele in women non-smokers than in women smokers, with IHD (nonsmokers: TT, CT 
and CC: 9.5, 37.7 and 52.8 %, smokers: 12.4, 44.5 and 43.1 %, p = 0.038). Significant 
differences were also found between women with IHD and control population with 
regard to smoking status. No such differences were found in male population. Similar 
results were observed in the population from Romania, with borderline significance (p = 
0.09).  Data from Hungary and Croatia when stratified by gender and smoking status did 
not reach statistical significance because of smaller sample size.  
Conclusion: Our results indicate that the T allele could be protective against 
manifestation of ischemic heart disease in female non-smokers while male gender and 
history of smoking abolishes this positive effect. In general, impact of particular gene 
variant could be extremely dependent on risk profile of the population under study.   
Key Words: connexin 37 gene – ischemic heart disease- gender – smoking 
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Aim: We studied the gender-specific differences in advanced glycation end-products 
(AGEs) and advanced oxidation protein products (AOPPs) in young-to-early-middle-
aged general population.  
Methods: In 437 (183M/254F) apparently healthy volunteers aged 33±11 years plasma 
levels of Nε-(carboxymethyl)lysine (CML, chemically defined AGE product), AGE-
specific fluorescence, levels of soluble receptor for AGEs (sRAGE) and advanced 
oxidation protein products were determined. Waist circumference was recorded and 
insulin sensitivity was determined (Quantitative insulin-sensitivity check index - 
QUICKI). Student’s T-test was used to compare 2 groups, and General linear model to 
assess the impact of gender, waist circumference and insulin sensitivity on above 
mentioned biomarker’s levels.   
Results: Males and females did not differ significantly by age and QUICKI. Males 
presented higher waist circumference (M: 93±11 cm, F: 78±11 cm, p<0.001), lower CML 
(M: 1.2±0.2 ug/ml, F: 1.3±0.3 cm, p<0.001), and sRAGE (M: 1.2±0.4 ng/ml, F: 1.3±0.4 
ng/ml, p<0.05) levels, but higher AOPPs (M: 79±47 umol/l, F: 70±40 umol/l, p<0.02). 
No significant difference in AGE-specific fluorescence was revealed. General linear 
model revealed that waist circumference imposed the main significant impact on CML, 
fluorescent AGEs and sRAGE levels. It failed to reveal significant gender-specific 
impact, effect of waist circumference or QUICKI on AOPP levels 
Conclusions: Mild but significant differences in plasma CML and sRAGE between 
young-to middle-aged apparently healthy males and females are mainly on the account of 
waist circumference.  
Keywords: central obesity, insulin sensitivity, gender, advanced glycation end products, 
sRAGE, advanced oxidation protein products 
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Left ventricular diastolic dysfunction (DD) occurs in various cardiovascular diseases. DD 
develops during normal cardiac aging and manifests not only in heart failure with 
preserved and reduced ejection fraction (HFPEF and HFREF, respectively), but also in 
diabetic cardiomyopathy, aortic valve stenosis, hypertrophic cardiomyopathy (HCM) and 
Fabry disease (FD). Mechanisms leading to DD are divergent, and involve 
cardiomyocyte dysfunction, transcriptional and post-translational myofilamentary protein 
alterations, as well as abnormalities of the extracellular matrix. Moreover, the relative 
contribution of the distinct territories widely differs among these diseases. 
Increased collagen deposition along with collagen cross-linking by advanced glycation 
end-products (AGEs) is proposed as the main determinant in the senescent heart. 
Increased production of reactive oxygen species and involvement of the renin-
angiotensin system have been implicated in the background of fibrosis. In HFPEF high 
cardiomyocyte resting tension was shown to contribute to the myocardial stiffening. 
Elevated cardiomyocyte resting tension was also implicated in diabetic patients with 
HFNEF, whereas in diabetic patients with HFREF AGEs deposition and fibrosis were 
identified as major contributors to increased LV stiffness. In contrast to HFNEF, patients 
with aortic valve stenosis develop not only diastolic, but also systolic dysfunction, which 
is attributed to a complex inflammatory process involving similar mechanisms as those 
leading to atherosclerosis. Genetically determined diseases (HCM and FD) also exhibit 
diastolic dysfunction. While in HCM mutation of a sarcomeric protein leads to 
development of myocardial remodeling, FD is associated with an enzyme deficiency, 
which induces the progressive glycosphingolipid deposition in cardiomyocytes and 
consequent contractile dysfunction. 
The divergent set of mechanisms underlying impaired diastolic function requires not only 
complex experimental and clinical investigations, but also individually designed 
therapeutic approaches, which aim to improve the function of the pathologically 
remodeled heart. 
Keywords: cardiomyocytes, contractile dysfunction, diabetes mellitus, diastole, fibrosis, 
human heart. 
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Aim: The key role of vitamin D (VD) in the control of bone metabolism, Ca and P 
homeostasis is well-known. VD acts through vitamin D receptor and directly or indirectly 
affects the transcription of more than 200 target genes. Except skeletal effects, there are 
also a wide variety of non-skeletal effects of VD on the regulation of the cell 
differentiation and proliferation, hormones secretion and on the modulation of immune 
system. There is a lack of data on VD deficit in Slovakia. Thus, the aim of our study was 
to determine VD status in healthy adults in Slovakia.   
Methods: The study sample comprised 1213 apparently healthy subjects (851F/ 362M) 
drawn from existing prospective cohorts of adults living in Bratislava and west Slovakia. 
The study was carried out during winter and spring. No supplementation of VD was 
allowed. Body mass index (BMI) was calculated and serum concentrations of 25-
hydroxyvitamin D (25(OH) D) and intact parathormone (PTH) were analysed.  
Results: The genders were similar in age range (F: 15-80; M: 15-83), but men had 
significantly higher BMI (p<0.0001) and 25(OH) D (p<0.0001) and lower PTH 
(p<0.041). Strong relationship between 25(OH)D and BMI (p<0.0004) was found in all 
group and in both geneders separately. A similar pattern emerged for the association 
between 25(OH)D and age (p<0.0002). VD insufficiency (20-30 ng/ml) was found in 
26% of men and in 30% of women (p<0.001) and VD deficit (<20 ng/ml) was found in 
29% of men and in 36% of women (p<0.001).  
Conclusion: VD deficiency and insufficiency are common in Slovak healthy adults. Low 
VD levels correlates with age, BMI and sex. Due to the possible links between low VD 
status and disease risk we recommend to improve vitamin D intake through supplements.   
 
Supported by: Research and development program financed from the European Regional 
Development Fund, project ITMS No.24240120033. 
 
Key words: vitamin D status, population 
  30
Simultaneous quantification of soluble fibrin, DD and Fg in clinics 
 
Lugovskoi E. V., Kolesnikova I. N., Komisarenko S. V. 
AV Palladin Institute of Biochemistry, NAS of Ukraine 
9, Leontovicha Str. Kiev, Ukraine, 01601 
lougovskoy@yahoo.com  
 
Aim: To show the diagnostic importance of simultaneous quantification of soluble fibrin 
(Sf), D-dimer (DD) and fibrinogen (Fg) at various diseases.  
Methods: Quantification of Sf, DD and Fg was performed by ELISA using three test-
systems designed in our department. 
Results: Quantification of Sf and DD in donor blood plasma showed that Sf 
concentration is on average 3-3.5 g/ml and DD concentration – 120 ng/ml. Such 
measurements give integral information about the state of coagulation system and 
fibrinolysis at TELA, DVT, DIC syndrome, caesarean operation, arteriovenous form of 
angiodisplasy, and abdominal aortic aneurysm. Simultaneous measurements of Sf, DD 
and Fg are useful to diagnose and monitor antithrombotic and thrombolytic therapy 
including post-operation period. It has been shown the increased concentrations of these 
molecular markers positively correlate with the seriousness of blood vessel complications 
in patients, suffering from diabetes mellitus.  
Conclusions: Simultaneous quantification of Sf, DD and Fg gives very useful diagnostic 
information about the state of haemostasis system. 
 
Fig. Soluble fibrin and D-dimer contents in blood plasma of health individuals (N) and 
patients suffering from diabetes mellitus with initial (1), medium (2) and severe (3) blood 
vessel complications. 
Keywords: soluble fibrin; DD; fibrinogen; simultaneous quantification in clinics 
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Aim: Nowadays conception of cellular cardiomyoplasty consist in preventing the 
progression and consequence of cardiac disease (CD), and also enhancing regeneration of 
damaged tissues. Cell-based myocardial regeneration is currently being explored for a 
wide range of CD, including acute and chronic ischemic myocardial damage and 
cardiomyopathy. The goal of cell therapy for heart failure is improving cardiac function, 
accordingly with inhibition of remodeling process. Ideally, transplanted stem cells (SCs) 
would replace and mimic the lost cardiomyocytes morphologically and functionally 
showing the ability to contract and to establish electrical connectivity with the native 
cells.  
Methods: Different SC types have been tested and the methods of their introduction and 
delivery to damaged myocardium have been developed by using experimental models.   
Results: At least two types of bone marrow-derived SCs, skeletal myoblasts, cardiac 
stem and progenitor cells, embryonic SCs, endothelial progenitor and precursor cells 
have been investigated in experimental models, and they revealed different potential for 
differentiation to cardiomyocytes and stimulation of myocardial regeneration. Two 
fundamental mechanisms by which SCs may repair damaged myocardium have been 
established: 1) direct or indirect improvement of neovascularization; 2) differentiation 
into cardiomyocytes and formation of heart tissue. Functional improvement may also be 
mediated through paracrine secretion of growth factors and cytokines which indirectly 
promote survival of cardiomyocytes by inhibition of apoptosis, and may also lead to 
mobilization of endogenous progenitor cells. Address delivery of SCs to damaged 
myocardium zones is being developed by using nanoparticles in experimental models. 
During last years a few clinical protocols have been approbated in clinics of USA, 
Europe and Russia.  
Conclusions: According the results of selected clinical trials the methods of cellular 
cardiomyoplasty are safe for health of patients and their application in the scheme of 
treatment lead to improvement of cardiac function. But there is a big difference in 
individual response on the introduction of exogenous cells or cellular products. 
Keywords: cell cardiomyoplasty, stem cells, myocardial regeneration 
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Aim: Adiponectin (ADIPOQ), protein produced by adipose cells, has antiatherogenic 
effect while interleukin 6 (IL6) and tumor necrosis factor (TNFa) have proatherogenic 
effect. Aim of this study was to determine concentrations of ADIPOQ, IL6 and TNFa in 
aortic root (AR) and coronary sinus (CS) along with transcardiac gradients in CAD 
patients. 
Methods: Of 36 patients who underwent coronarography 16 of them had CAD. Blood 
samples were taken from AR and CS. Concentrations of IL6, TNFa and ADIPOQ were 
obtained by commercially available kits. 
Results: IL6 showed a decrease in concentration from AR to CS, CAD patients had 
significantly higher concentrations (p=0.012) (5.81 Me=5.10; 4.35 Me=4.50 pg/ml) in 
CS. TNFa did not show significant difference throughout heart and in between groups. 
CAD patients had significantly lower (p<0.001) concentrations of ADIPOQ in AR (2.67 
± 1.27; 5.68± 3.10 µg/ml) and significantly lower (p=0.002) concentrations in CS (3.89 ± 
2.23; 6.86 ± 3.57 µg/ml). Transcardiac gradient, concentration ratio of coronary sinus to 
aortic root, with average value for IL6 less than 1, did not show significant difference 
between groups, same as TNFa, where ratio was barely above 1.There was no significant 
difference between groups. Transcardiac gradient for ADIPOQ was significantly higher 
(p=0.018) in CAD group (1.47 ± 0.31; 1.23 ± 0.25). 
Conclusions: CAD patients have decreased levels of adiponectin, higher transcaridac 
gradient and increased levels of IL6 in CS. 
Keywords: adiponectin, CAD, adipose tissue 
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Aim: To study dynamics of anti-mullerian hormone (AMH) for perimenopausal women 
for timely correction of menopausal disorders and prevention of cardiovascular accidents. 
Methods: Levels of AMH, low-density lipoprotein-cholesterol (LDL-C), numbers of 
antral follicles (AF) by ultrasound scan, were studied on 69 women (age 46,69±3,21 
y.o.), who have initial involutive changes. 39 women (group I) have cardiovascular 
diseases (CVD) history (arterial blood pressure > 135/85 mmHg and/or heart attack 
episodes), 30 women (group II) don’t have CVD history. 
Results: Group I: noted positive correlation between AMH level (0,54±0,38 ng/mL) and 
numbers of AF (2,28±1,32) (r= +0,85); also noted negative correlation between AMH 
and LDL-C (132,97±8,86 mg/dL)  (r= -0,54). Group II: AMH level was 2,58±0,32 
ng/mL, LDL-C level was 105,04±12,3 mg/dL (r AMH-LDL-C= -0,46); numbers of AF 
were 4,92±1,35 (r AMH-AF = +0,76). In 27 women from I group after 3 month of 
Replacement Hormone Therapy (RHT) LDL-C decreasing from 134,82±9,94mg/dL to 
119,27±4,45mg/dL, (p<0,05). These changes were accompanied by reduced numbers of 
CDV events and reduction of early climacteric symptoms. In 12 women from I group, 
who didn’t use RHT, trends to increasing of LDL-C were detected (from 
129,±5,17mg/dL to 136,41±2,32), numbers CDV events did not change, climacteric 
autonomic disorders and anxious or depressive episodes were continued. 
Conclusions: AMH control for perimenopausal women with CVD history must be done 
every 3 month for timely correction of menopausal disorders and prevention of 
cardiovascular accidents. Reduction of AMH for perimenopausal women more than 
factor of 10 within a short time is the evidence of premature aging of the ovarian and of 
lowering of hormonal protection of vessels. Appointment of RHT for hormone deficiency 
contributes into the normalization of lipid profile, CVD prevention and the improvement 
of quality of life. 
 
Key words: Anti-Mullerian Hormone, cardiovascular risks, Replacement Hormone 
Therapy.  
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Aim: C-reactive protein (CRP), when associated with noninvasive parameters, improves 
prediction of outcomes in patients with acute coronary syndrome (ACS). The aim of this 
study was to improve the prognostic and predictive value of C-reactive protein (CRP) in 
acute coronary syndrome (ACS) settings by combining it with a number of other 
noninvasive parameters obtained at the time of presentation to the hospital, creating 
simple procedure affordable to majority of doctors. 
Methods And Results: When CRP is linked to certain noninvasive parameters, such as 
risk factors number, leukocytes, hemoglobin, total cholesterol, low-density lipoprotein, 
total cholesterol and high-density cholesterol ratio, microalbuminuria, brain natriuretic 
peptide or its precursor, fibrinogen, antithrombin III, troponin, duration of QRS complex, 
ventricular ectopic activity by Lown’ classification, NYHA functional class, standard 
deviation of all normal nonectopic RR intervals, silent and symptomatic myocardial 
ischemia observed by ambulatory electrocardio-graphic monitoring and pulse recovery 
after treadmill exercise testing, accurately prediction of the medium-term outcome in 
patients with ACS can be achieved. To obtain such prognosis, the author has created 
original score procedure. 
In order to create conditions for comparing different indicators transformation of all these 
parameters was made to form a unique scoring system. Values of parameters were 
classified into three basic groups: normal, less adverse and more adverse. Nominal values 
of parameters were associated with the empirically-driven numerical values. An award 
system of parameters was created, and dependent relationship as well, which made 
possible calculation of the medium-term prognosis in ACS patients. 
 
 
 
 
                           Sbv = (CRPCRPbv)                          +(NeP NePbv) 
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SUM OF CRP AND 18 PARAMETERS CONVERTED VALUES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pyramid of outcomes is also an empirical product which, based on the summary score of 
CRP and the selected parameters, allows easy and reliable classification of patients with 
ACS the risk groups, and consequently, the individualization of further therapeutic 
procedures or treatment on each patient. 
Based on the hypothesis testing was performed on 247 patients lasting more than two 
years. 
Test results have confirmed the validity of the hypotheses. 
 
Conclusion: Study has confirmed that the prognostic value of CRP in ACS patients can 
be improved, by linking CRP with some noninvasive parameters. New system of values 
was created; the prognostic relations and the Pyramid of the outcomes were formed.  
The intension of the author is to make software program in order to simplify procedure. 
 
Key Words: C-reactive protein, Acute Coronary Syndrome, Unstable Angina, NSTEMI, 
STEMI 
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